Ackermans & van Haaren

A diversified group active in Marine Engineering & Infrastructure (DEME, Algemene Aannemingen Van Laere), Private Banking, Real Estate, Leisure & Senior Care, Energy & Resources, and Development Capital. It aims to create shareholder value through long-term investments in companies with international growth potential.

John-Eric Bertrand

Co-CEO and Co-Chairman of the Executive Committee

Piet Bevernage

Executive Committee Member and Secretary General

Jeroen Vangindertael

Investment Manager

14 past transactions

Biotalys

Post in 2024
Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Vico Therapeutics

Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Vico Therapeutics

Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Camlin Fine Sciences

Post in 2023
Camlin Fine Sciences Limited is a Mumbai-based company engaged in the research, development, manufacturing, and marketing of specialty chemicals and additive products. With a global presence, it operates in markets across India, Mexico, North America, Europe, and Asia. The company specializes in providing shelf-life extension solutions, which include antioxidants and natural products aimed at enhancing the longevity of food and feed. Its portfolio includes aroma ingredients like vanillin and ethyl vanillin, as well as nutraceutical products derived from fermentation and green extraction sources. Camlin Fine Sciences also produces performance chemicals and various animal nutrition products, such as growth promoters and antimicrobials. The products cater to diverse industries, including food and beverage, agriculture, pharmaceuticals, and petrochemicals. Founded in 1931, the company was previously known as Camlin Fine Chemicals and rebranded in 2011 to reflect its broader focus on specialty chemicals.

AstriVax

Seed Round in 2022
AstriVax is a vaccine developer focused on a platform technology to create a broad vaccination pipeline aimed at initial clinical validation and addressing real-world vaccinology challenges. Its vaccines are designed to reduce cold chain requirements and provide broad, long-lasting protection against multiple viruses and pathogens.

Medikabazaar

Series D in 2022
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Medikabazaar

Series C in 2021
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Medikabazaar

Series B in 2020
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

MRM Health NV

Series A in 2020
MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, specializing in the development of microbiome-based therapeutics aimed at treating metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies N.V., the company focuses on innovative drug discovery, notably its lead candidate MH002, which targets Inflammatory Bowel Disease (IBD), encompassing conditions such as Ulcerative Colitis and Crohn's disease. MRM Health was established in collaboration with the Flemish Institute of Biotechnology, leveraging expertise in microbiome research to translate scientific discoveries into effective therapeutic applications.

OncoDNA

Series B in 2020
Founded by experts in DNA sequencing and diagnostic analyses in oncology, OncoDNA offers precision medicine solutions for cancer treatment. It provides clinical guidance for late-stage patients, supports research, and aids drug development.

Medikabazaar

Series B in 2019
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Biotalys

Series C in 2019
Biotalys is an agricultural technology company based in Ghent, Belgium, founded in 2013. The company specializes in researching and developing biopesticides designed to control pests and diseases on crops and harvested products. Biotalys employs its proprietary Agrobody technology platform to create protein-based biocontrol solutions that combine the effectiveness of chemical pesticides with the safety profile of biologicals. These solutions are suitable for both pre- and post-harvest applications, aiming to provide a more sustainable and safer food supply. The company's technology platform generates products that enable targeted delivery and retention of active ingredients to prevent and control weeds, pests, and diseases.

Biolectric

Acquisition in 2019
Biolectric develops innovative biogas installation sets designed to enhance biogas energy production. Its core process involves microbiological conversion of organic material under anaerobic conditions, eliminating the need for additional organic waste and reducing energy production costs while promoting eco-friendly energy solutions.

OncoDNA

Series A in 2016
Founded by experts in DNA sequencing and diagnostic analyses in oncology, OncoDNA offers precision medicine solutions for cancer treatment. It provides clinical guidance for late-stage patients, supports research, and aids drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.